Upon recurrence of the tumor, the patient was effectively treated with RT followed by anti-programmed death-1 (anti-PD-1) immunotherapy utilizing toripalimab injection combined with anti-VEGFR therapy using anlotinib capsules, achieving a response of SD with tumor shrinkage. The gene discussed is KDR; the disease is neoplasm.